Filters
This feature is available to registered users. Create a free account to unlock access.
View trials that will begin recruiting soon
Search hospitals, biomarkers, trial titles, and NCT IDs
0 trials found
MRD Trials
Minimal Residual Disease (MRD) refers to microscopic cancer cells that may remain after treatment, detected through sensitive ctDNA blood tests before they're visible on scans. MRD trials focus on treating these cells early, before they have a chance to grow or cause recurrence.
This page is open to everyone and does not require an account (though Second Look Cancer offers a more personalized and better experience when you're logged in).
If you know someone who may benefit from learning about MRD trials, feel free to share this link: secondlookcancer.com/mrd-trials